Viemed Healthcare Inc SEC Filings

Kaushal Nitin, a director of Viemed Healthcare, Inc. (VMD), reported equity awards and increases in beneficial ownership. The filing shows transactions on August 19–20, 2025 in which the reporting person acquired 15,732 common shares and received restricted stock unit grants totaling 34,518 RSUs across two grant dates. One RSU grant from August 20, 2024 vested August 20, 2025 and corresponds to 15,732 shares; a separate RSU grant on August 19, 2025 vests August 19, 2026 for 18,786 shares. Following the reported transactions, the filing lists 142,575 common shares as beneficially owned by the reporting person. The form is signed by an attorney-in-fact.

Timothy Smokoff, a director of Viemed Healthcare, Inc. (VMD), received equity awards in August 2025. The Form 4 shows grants and the resulting ownership changes: 15,732 restricted stock units (RSUs) were reported as acquired on 08/20/2025 and 15,029 RSUs plus 3,757 phantom share units were acquired on 08/19/2025. After the 08/20/2025 transaction the filing shows the reporting person beneficially owned 95,518 common shares. The RSUs granted vest on specified future dates, and each phantom share represents a right to receive the cash value of one common share at vesting.

Randy E. Dobbs, a director of Viemed Healthcare, Inc. (VMD), reported changes in his beneficial ownership of the issuer's common stock on transactions dated 08/19/2025 and 08/20/2025. The filing shows a grant and vesting activity: Restricted Stock Units (RSUs) and Phantom Share Units were granted on 08/19/2025 (16,763 RSUs and 4,191 phantom units) that vest on 08/19/2026, and RSUs granted on 08/20/2024 that vest on 08/20/2025 are referenced in the explanations.

The reported result of the 08/20/2025 activity is an acquisition entry of 17,784 common shares (code M) and a reported total of 125,490 shares beneficially owned following the reported transaction(s). The filing was signed by an attorney-in-fact on 08/20/2025.

Sabrina Heltz, a director of Viemed Healthcare, Inc. (VMD), reported equity awards and changes in beneficial ownership in August 2025. The Form 4 shows grants and vesting events: on 08/19/2025 she was granted 15,029 restricted stock units (RSUs) that vest on 08/19/2026 and 3,757 phantom share units that vest on 08/19/2026. On 08/20/2025 a previously awarded 15,732 RSUs vested and were acquired, and after the reported transactions she beneficially owned 67,491 common shares. Phantom shares pay cash based on the issuer's share price at vesting. The filing was signed by an attorney-in-fact on behalf of the reporting person.

Jerome Cambre, Vice President of Sales at Viemed Healthcare, Inc. (VMD), reported two open-market sales of common shares on 08/13/2025. He sold 1,580 shares at $7.33 and 3,300 shares at $7.32, a total of 4,880 shares. Following these transactions his beneficial ownership is reported as 84,191 shares. The filing was signed by an attorney-in-fact on 08/14/2025. No derivative securities were reported on this Form 4.

Michael Moore, President of Viemed Healthcare (VMD), reported an insider sale. The Form 4 shows a sale of 50,090 common shares on 08/12/2025 at a price of $7.33 per share. After the transaction Moore directly owns 126,343 shares and indirectly beneficially owns 1,722,614 shares through Moore Faster LLC. The filing discloses the sale but provides no context about volume relative to total outstanding shares.

Michael Moore, President of Viemed Healthcare (VMD), filed an amended Form 4 to correct his reported holdings after a sale. The amendment records a disposal of 8,948 common shares tied to the market closing price on 01/29/2025 with a per-share value shown as $8.28. The corrected post-transaction beneficial ownership is 176,433 shares, amended from an earlier reported 177,433 shares. The filing states the original error affected a prior Form 4 filed July 1 and that subsequent filings will reflect the corrected balance.

Viemed Healthcare, Inc. filed a Form S-8 to register an additional 412,351 common shares for issuance under the Viemed Healthcare, Inc. 2024 Long Term Incentive Plan, as amended. The amendment adding these shares was approved by shareholders at the companys 2025 annual meeting on June 5, 2025. Upon effectiveness, the total shares available for issuance under the 2024 Plan will be 7,904,757. The filing incorporates by reference a prior S-8 filed on August 12, 2024 (File No. 333-281502). The registrant is identified as an accelerated filer and lists British Columbia as its jurisdiction of incorporation and Lafayette, Louisiana as its principal executive office.